Javascript must be enabled to continue!
TIP60 mediated regulation of ΔNp63α is associated with Cisplatin resistance
View through CrossRef
About 5.4 million basal and squamous cell skin cancers are diagnosed each year in the US. Cisplatin, a chemotherapeutic drug is often used to treat squamous cell carcinoma (SCC) patients. However, 55% of cancers fail to respond leading to lower response rates and higher rates of disease re‐occurrence. ΔNp63α a member of the p53 transcription factor family is overexpressed and considered oncogenic in non‐melanoma skin cancer where it regulates cell survival and proliferation. TIP60 (Tat‐interacting protein 60kDa), a histone acetyltransferase has been shown to mediate cellular processes such as transcription regulation and the DNA damage response (DDR). We recently reported that TIP60 positively regulates ΔNp63α protein levels in a catalytic‐dependent manner to promote SCC proliferation. Since ΔNp63α is known to transcriptionally regulate several DDR genes and promote resistance to cisplatin, its stabilization by TIP60 may contribute to the failure of platinum‐based drugs in SCC. We hypothesis that TIP60 mediated acetylation of ΔNp63α regulates its transcriptional activity thereby modulates chemoresistance. In this study, we showed that silencing of endogenous TIP60 in multiple SCC cell lines led to decrease in ΔNp63α transcript and protein levels confirming that TIP60 positively regulates ΔNp63α. Increased levels of TIP60 positively correlated with increased ΔNp63α expression and contributes to cisplatin resistance. Further, stable expression of TIP60 or ΔNp63α individually promoted resistance to cisplatin and reduced cell death, whereas loss of ΔNp63α and TIP60 sensitized cells to cisplatin. Higher acetylation of ΔNp63α and TIP60 were seen in cisplatin resistant cell line. Taken together, our data suggest that TIP60‐mediated stabilization of ΔNp63α increases cisplatin resistance and has potential implication for SCC cancer treatment and drug design. Additionally, since ΔNp63α confers cisplatin resistance through regulation of genes involved in DNA damage repair, our findings provide critical insights into the mechanism by which genes involved in chemoresistance are regulated and may lead to strategic treatment for resistant SCC tumors and other epithelial cancers with increased efficacy.
Title: TIP60 mediated regulation of ΔNp63α is associated with Cisplatin resistance
Description:
About 5.
4 million basal and squamous cell skin cancers are diagnosed each year in the US.
Cisplatin, a chemotherapeutic drug is often used to treat squamous cell carcinoma (SCC) patients.
However, 55% of cancers fail to respond leading to lower response rates and higher rates of disease re‐occurrence.
ΔNp63α a member of the p53 transcription factor family is overexpressed and considered oncogenic in non‐melanoma skin cancer where it regulates cell survival and proliferation.
TIP60 (Tat‐interacting protein 60kDa), a histone acetyltransferase has been shown to mediate cellular processes such as transcription regulation and the DNA damage response (DDR).
We recently reported that TIP60 positively regulates ΔNp63α protein levels in a catalytic‐dependent manner to promote SCC proliferation.
Since ΔNp63α is known to transcriptionally regulate several DDR genes and promote resistance to cisplatin, its stabilization by TIP60 may contribute to the failure of platinum‐based drugs in SCC.
We hypothesis that TIP60 mediated acetylation of ΔNp63α regulates its transcriptional activity thereby modulates chemoresistance.
In this study, we showed that silencing of endogenous TIP60 in multiple SCC cell lines led to decrease in ΔNp63α transcript and protein levels confirming that TIP60 positively regulates ΔNp63α.
Increased levels of TIP60 positively correlated with increased ΔNp63α expression and contributes to cisplatin resistance.
Further, stable expression of TIP60 or ΔNp63α individually promoted resistance to cisplatin and reduced cell death, whereas loss of ΔNp63α and TIP60 sensitized cells to cisplatin.
Higher acetylation of ΔNp63α and TIP60 were seen in cisplatin resistant cell line.
Taken together, our data suggest that TIP60‐mediated stabilization of ΔNp63α increases cisplatin resistance and has potential implication for SCC cancer treatment and drug design.
Additionally, since ΔNp63α confers cisplatin resistance through regulation of genes involved in DNA damage repair, our findings provide critical insights into the mechanism by which genes involved in chemoresistance are regulated and may lead to strategic treatment for resistant SCC tumors and other epithelial cancers with increased efficacy.
Related Results
Abstract 400: TIP60-mediated regulation of DNp63a is associated with cisplatin resistance
Abstract 400: TIP60-mediated regulation of DNp63a is associated with cisplatin resistance
Abstract
About 5.4 million basal and squamous cell skin cancers are diagnosed each year in the US. The chemotherapeutic drug, Cisplatin is often used to treat squamo...
TIP60 regulation of ΔNp63α is associated with SCC proliferation
TIP60 regulation of ΔNp63α is associated with SCC proliferation
The transcription factor ΔNp63α, a p53 family member, is found primarily in the basal stratum of the skin where it functions to promote epithelial morphogenesis, cell proliferation...
Abstract 3910: Acetylation of ΔNp63α by Tip60 affects its stability
Abstract 3910: Acetylation of ΔNp63α by Tip60 affects its stability
Abstract
p63, a member of the transcription factor p53 family, exists as six different isoforms due to the usage of alternative promoter sites and splicing. ΔNp63α i...
Identification of dTip60 binding partners by bioinformatic analysis of chIP-Seq data
Identification of dTip60 binding partners by bioinformatic analysis of chIP-Seq data
Tip60 is a histone acetyltransferase that has recently been shown to play a significant role in various neuronal functions of Drosophila, including synaptic plasticity and axonogen...
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
Abstract 1490: RAD51C-deficient cancer cells require DNA polymerase zeta to bypass cisplatin-induced lesion
RAD51C is a RAD51 paralog protein that mediates RAD51 filament formation on single-stranded DNA (ssDNA) in a canonical homologous recombination (HR) pathway. This step is vital for...
Understanding cisplatin resistance using cellular models
Understanding cisplatin resistance using cellular models
AbstractMany mechanisms of cisplatin resistance have been proposed from studies of cellular models of resistance including changes in cellular drug accumulation, detoxification of ...
Abstract 1598: Epigenetic priming using azacitidine improves cisplatin response in diffuse large B-cell lymphoma cell lines via endogenous retroviruses induced viral mimicry
Abstract 1598: Epigenetic priming using azacitidine improves cisplatin response in diffuse large B-cell lymphoma cell lines via endogenous retroviruses induced viral mimicry
Abstract
Background and purpose Although majority of patients with diffuse large B-cell lymphoma (DLBCL) achieve and complete remission after first-line rituximab-CH...
Abstract 232: Cancer stem cells and cisplatin.
Abstract 232: Cancer stem cells and cisplatin.
Abstract
Introduction:
Cisplatin is an important chemotherapeutic agent, which has resulted in higher overall response rates when combined with 5-FU o...

